Once-a-month risedronate in postmenopausal osteoporosis. Commentary
- PMID: 19641267
- DOI: 10.3810/pgm.2009.07.2028
Once-a-month risedronate in postmenopausal osteoporosis. Commentary
Comment on
-
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.Bone. 2008 Jan;42(1):36-42. doi: 10.1016/j.bone.2007.09.001. Epub 2007 Sep 8. Bone. 2008. PMID: 17920005 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources